resbiotic teams up with Tiny Health to bring res

Scribe Therapeutics presented late-breaking precl

Human Longevity, Inc.

On 27 May 2026, Verge Labs, formerly Verge Genomi

Ribo has submitted a Phase 2 clinical trial appli

Avaí Bio and Austrianova’s Nevada joint ventur

SynuSight Biotech announced a collaborative study

BioCardia reported that Japan’s Pharmaceutical

ABILITY Neurotech wins approval for the first lo

California-based startup bets on AI-designed bio

ArentFox Schiff’s Gayland Hethcoat on navigati

Multimillion-dollar collaboration shifts the len

Insilico Medicine and Human Life Foundation Model

NeuroXT announced the completion of an initial re

Jupiter Neurosciences has begun patient enrollmen

Therini Bio has dosed the first patients in a Pha

Startups spanning AI, women’s health, diagnost

TFG-001 therapy restored brain connections faste

The partnership brings data-driven men’s healt

Biogen and Ionis report first Phase 2 evidence t

Harvard Health Publishing’s first longevity re

Scribe Therapeutics has secured clearance from Au

Alzinova is preparing for a global phase II study

MBX Biosciences, Inc.

Biotech firms, including Regenxbio, Novartis and

The Korean Society of Hypertension has incorporat

Korean pharma company targets regenerative medic

Milan panel explores how longevity medicine is s

Sam Altman-backed longevity startup moves deeper

European platform ties biomarker data to clinica

New trial data suggest Eli Lilly’s next-gen we

Retro Biosciences, a leading biotechnology compan

Emagene.

HCW Biologics completed a $4 million private plac

TreeFrog Therapeutics will present new preclinica

Open-source system uses adversarial AI workflows

FDA-cleared Sunrise Air could reshape how sleep

Partnership with RegenTherapy reflects growing d

What if wearables could predict hormonal shifts

Mabwell will present multiple clinical datasets f

ProHealth’s BPC-157 Ultra Probiotic is presente

Resbiotic has launched the at-home Resbiotic Gut

ProHealth has detailed Essentials NMN 500, a 500

Experimental pill targets one of the brain’s m

New physician training program reflects China’

Policy, biotech and geroscience converge in DC a

Latest preclinical data from ASGCT 2026 suggest

Codexis presented advances at TIDES USA 2026 in B

Scribe Therapeutics has secured clearance from th

Cognition Therapeutics completed a planned meetin